ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Side Effect Management
Gynecomastia and Hormones
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 39385" data-attributes="member: 3"><p>Gynecomastia, commonly described as the enlargement of the male breast tissue, is clinically characterized by the presence of a mass extending concentrically from the nipple (e.g., bilateral or rarely unilateral). Gynecomastia is the most common breast alteration in males [1], occurring more frequently during infancy, puberty, and old age [1, 2]: prevalence rates, as suggested by Johnson et al. [3], are 60–90 % in newborns, 50–60 % in adolescents, and 70 in men between 50 and 69 years.</p><p></p><p>Physical examination and careful medical history are invaluable tools in the assessment of a patient with breast enlargement. Palpation allows to rule out lipomastia, the accumulation of subareolar fat in the absence of a solid palpable disk of glandular tissue [4].</p><p></p><p>Histologically, true gynecomastia is mainly characterized by ductal epithelial hyperplasia and increase in stro- mal and periductal connective tissue [1], usually resulting from increased action of exogenous or endogenous estra- diol (E2) and absolutely or relatively reduced effects of androgens (i.e., testosterone, T) [5] (Table 1). Referrals to breast clinic assessment are increasing [6] for preventive, aesthetic, and therapeutic reasons; however, in most cases, gynecomastia resolves spontaneously [5, 7]. Despite its frequent benignity, it is often cause for psychological dis- tress [8]: fear of diseases (including breast cancer) and psychosocial discomfort are common complaints which should not be disregarded by the clinician [6, 8].</p><p></p><p>Physiological gynecomastia occurs in up to 25 % of patients [9]; likewise, no definite cause is identifiable in another 25 % of cases [9]. In the remaining half of the affected subjects, gynecomastia is either iatrogenic, or related to an underlying condition which should be iden- tified and treated (Table 2).</p><p></p><p>Full Paper Attached</p><p></p><p>[ATTACH=full]7778[/ATTACH]</p><p></p><p>[ATTACH=full]2070[/ATTACH][ATTACH=full]2069[/ATTACH]</p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 39385, member: 3"] Gynecomastia, commonly described as the enlargement of the male breast tissue, is clinically characterized by the presence of a mass extending concentrically from the nipple (e.g., bilateral or rarely unilateral). Gynecomastia is the most common breast alteration in males [1], occurring more frequently during infancy, puberty, and old age [1, 2]: prevalence rates, as suggested by Johnson et al. [3], are 60–90 % in newborns, 50–60 % in adolescents, and 70 in men between 50 and 69 years. Physical examination and careful medical history are invaluable tools in the assessment of a patient with breast enlargement. Palpation allows to rule out lipomastia, the accumulation of subareolar fat in the absence of a solid palpable disk of glandular tissue [4]. Histologically, true gynecomastia is mainly characterized by ductal epithelial hyperplasia and increase in stro- mal and periductal connective tissue [1], usually resulting from increased action of exogenous or endogenous estra- diol (E2) and absolutely or relatively reduced effects of androgens (i.e., testosterone, T) [5] (Table 1). Referrals to breast clinic assessment are increasing [6] for preventive, aesthetic, and therapeutic reasons; however, in most cases, gynecomastia resolves spontaneously [5, 7]. Despite its frequent benignity, it is often cause for psychological dis- tress [8]: fear of diseases (including breast cancer) and psychosocial discomfort are common complaints which should not be disregarded by the clinician [6, 8]. Physiological gynecomastia occurs in up to 25 % of patients [9]; likewise, no definite cause is identifiable in another 25 % of cases [9]. In the remaining half of the affected subjects, gynecomastia is either iatrogenic, or related to an underlying condition which should be iden- tified and treated (Table 2). Full Paper Attached [ATTACH=full]7778[/ATTACH] [ATTACH=full]2070[/ATTACH][ATTACH=full]2069[/ATTACH] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Side Effect Management
Gynecomastia and Hormones
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top